This message was sent to ##Email## To advertise in this publication please click here November 12, 2020 .ASSOCIATION NEWS Webinar: Cell-free DNA in Kidney Transplantation – What Nurses Need to Know ITNS members are invited to join Natera to hear from Mayon Ashton, MSN, RMN, RN-BC on what nurses need to know about cell-free DNA in kidney transplantation. This presentation will review the basics of genetics leading into the use of Cell-free DNA (cfDNA). cfDNA is the term used to describe the small fragments of DNA that occur naturally and circulate in the bloodstream. Register Today! .INDUSTRY NEWS Detection of SARS-CoV-2 antibodies in kidney transplant recipients Journal of the American Society of Nephrology In this study, researchers analyze the seroprevalence of SARS-CoV-2 antibodies in a transplant population. In order to ensure the accuracy of the seroprevalence rate, this study also evaluates the performance of different serologic assays within this patient cohort. READ MORE Doctors successfully transplant heart despite helicopter crash — and organ dropping on floor The Independent A donated human heart that was involved in a helicopter crash on Nov. 6 while being carried for transplant surgery was also dropped on the floor by a medic during the chaos, it has now emerged. The heart was being carried from San Diego to Keck hospital in East Los Angeles by helicopter when the aircraft crashed onto the roof of the hospital. READ MORE  SPONSORED VIDEO Important Factors in Kidney Transplant Explore some of the many factors that can put a graft at risk, including CYP3A5*1 expression, declining adherence, and nephrotoxicity. In addition, review pharmacokinetic and clinical data that may be relevant to your practice and patients. See the Video WATCH VIDEO EGenesis taps Duke to help develop insulin-producing pancreas cell xenotransplants FierceBiotech EGenesis has announced a research collaboration with Duke University’s school of medicine to help develop its xenotransplantation technology into a cell therapy for diabetes. The project will begin evaluating insulin-producing pancreatic islet cells derived from animals that have been genetically engineered to be compatible with humans. This includes an in vivo study of the xenotransplants in primates to establish surgical approaches before moving forward to full clinical trials in the future. READ MORE Important considerations for drugs, nutritional, and herbal supplements in pediatric solid organ transplant recipients Physician's Weekly Pediatric transplant recipients are on multiple prescription and non-prescription drugs. Many patients also use dietary, nutritional, and herbal supplements. This manuscript researched formulations of immunosuppressive drugs currently available and presents information on generic immunosuppressive drugs, commonly used non-prescription medications, dietary supplements, and herbal supplements. READ MORE  SPONSORED CONTENT Promoted by Natera National Kidney Foundation CME Course: Evaluation of Acute Allograft Rejection in Kidney Transplantation KDIGO Webinar: The Critical Role of Genetics in Kidney Disease NEW: The Renasight Genetic Panel Can Inform the Care Path for Patients Diagnosed with CKD Learn about Prospera for a Better Kidney Transplant Rejection Assessment Why Prospera is the Right Choice for Managing Transplant Recipients Remotely No improvements seen in cancer incidence after kidney transplant during 3-decade period Healio A study of U.S. kidney transplant recipients showed no significant changes in cancer incidence during a period of three decades, with rates of graft failure and mortality remaining high. READ MORE The impact of multi-organ transplant allocation priority on wait-listed kidney transplant candidates American Journal of Transplantation Kidney‐alone transplant candidates may be disadvantaged by the allocation priority given to multi‐organ transplant candidates. This study identified potential KAT candidates not receiving a given kidney offer due to its allocation for MOT. READ MORE Advertisement  FEATURED ARTICLE   Financial support for kidney transplant patients Veloxis Pharmaceuticals Immunosuppressive medications can be a financial burden for kidney transplant patients, potentially costing as much as $10,000 to $14,000 a year. These expenses can have a negative impact on patients’ lives and may play a role in medication nonadherence, which is associated with transplant failure. Learn more about support that is available with a free 30-day trial to allow your patients to start immediately at no cost. And, for patients who are eligible with commercial insurance coverage, a $0 co-pay card offers significant savings. Find out more LEARN MORE   SNUH confirms safety of laparoscopic liver resection for donors Korea Biomedical Review Researchers said they have confirmed the safety and effectiveness of pure laparoscopic liver resection compared to open right hepatectomy in liver transplantation. The liver transplant team, led by Professor Suh Kyung-suk at the Seoul National University Hospital’s Hepatobiliary and Pancreatic Surgery Department, recently published the follow-up results of 894 people who donated their livers from 2010 to 2018. READ MORE Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients American Journal of Transplantation Kidney transplant recipients administered belatacept‐based maintenance immunosuppression present with a more favorable metabolic profile, reduced incidence of de novo donor‐specific antibodies, and improved renal function and long‐term patient/graft survival relative to individuals receiving calcineurin inhibitor‐based immunosuppression. However, the rates and severity of acute rejection are greater with the approved belatacept‐based regimen than with CNI‐based immunosuppression. READ MORE   ITNS Insider Connect with ITNS Dennis Hall, Director of Publishing, MultiView, 469-420-2656 | Download media kit Anne Casey, Content Editor, MultiView, 469-420-2619 | Contribute news International Transplant Nurses Society 8735 W. Higgins Road, Suite 300 | Chicago, IL 60631 847-375-6340  |  Contact Us  |  www.itns.org Click here to unsubscribe.  Learn how to add us to your safe sender list so our emails get to your inbox. ADVERTISE SUBSCRIBE PAST ISSUES   7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063